Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 1, 1997, Pages 103-109

  Kunitoh, Hideo ^a,b   Watanabe, Koshiro ^a   Nagatomo, Akira ^a   Okamoto, Hiroaki ^a   Kimbara, Kazuhiro ^a  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Accelerated hyperfractionation; Carboplatin; Chemoradiotherapy; Concurrent; Daily; Nonsmall cell lung cancer

Indexed keywords

CARBOPLATIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; PHARMACODYNAMICS; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; ESOPHAGITIS; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLATINUM; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0031057853     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00474-9     Document Type: Article

References (46)

1. Alvarez, M. V.; Cobreros, G.; Heras, A.; Lopez-Zumel. M. C. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br. J. Cancer 37:68-72; 1978.
2. Begg, A. C.; van der Kolk, H.; Dewit, L.; Bartelink, H. Radiosensitization by cisplatin of RIF-1 tumour cells in vitro, Int. J. Radiat. Biol. 50:871-884; 1986.
3. Bishop, J. F.; Ball, D.; Crennan, E.; Ryan, G.; Davis, S.; Toner, G.; O'Brien, P.; Olver, I. Radiation and carboplatin combined-modality therapy in nonsmall cell lung cancer. Semin. Oncol. 21(Suppl. 6):91-96; 1994.
4. Calvert, A. H.; Newell, D. R.; Gumbrell, L. A.; O'Reilly, S.; Burnell, M.; Boxall, F. E.; Siddik, Z. H.; Judson, I. R.; Gore, M. E.; Wiltshaw, E. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function. J. Clin. Oncol. 7:1748-1756; 1989.
5. Carde, P.; Laval, F. Effect of cis-dichlorodiammine platinum II and x-rays on mammalian cell survival. Int. J. Radiat. Oncol. Biol. Phys. 7:929-933; 1981.
6. Cockcroft, D. W.; Gault, M. H. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41; 1976.
7. Cox, J. D.; Azarnia, N.; Byhardt, R. W.; Shin, K. H.; Enami, B.; Pajak, T. F. A randomized Phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with >69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III nonsmall-cell lung carcinoma: Report of Radiation Therapy Oncology Group 83-11. J. Clin. Oncol. 8:1543-1555; 1990.
8. Dillman, R. O.; Seagren, S. L.; Propert, K. J.; Guerra, J.; Eaton, W. L.; Perry, M. C.; Carey, R. W.; Frei, E., III; Green, M. R. A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III nonsmall-cell lung cancer. N. Engl. J. Med. 323:940-945; 1990.
9. Douple, E. B.; Richmond, R. C. Radiosensitization of hypoxic tumor cells by cis-and trans-dichlorodiammine (II). Int. J. Radiat. Oncol. Biol. Phys. 5:1369-1372; 1979.
10. Dritschilo, A.; Piro, A. J.; Kelman, A. D. The effect of cis-platinum on the repair of radiation damage in plateau phase Chinese hamster (V-79) cells. Int. J. Radiat. Oncol. Biol. Phys. 5:1345-1349; 1979.
11. Green, M. R.; Kosty, M. P.; Muscato, J. J.; Graziano, S.; Dillman, R. O.; Clamon, G. H.; Herdon, J., II. Nonoperative management of nonsmall cell lung cancer: The current Cancer and Leukemia Group B experience. Semin. Oncol. 21(Suppl. 6):60-65; 1994.
12. Hazuka, M. B.; Bunn, P. A.. Jr. Controversies in the non-surgical treatment of stage III nonsmall cell lung cancer. Am. Rev. Respir. Dis. 145:967-977; 1992.
13. Hazuka, M. B.; Crowley, J. J.; Bunn, P. A., Jr.; O'Rourke, M.; Braun, T. J.; Livingston, R. B. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable nonsmall-cell lung cancer: Results of a phase II Southwest Oncology Group study. J. Clin. Oncol. 12:1814-1820; 1994.
14. Ihde, D. C. Chemotherapy combined with chest irradiation for locally advanced nonsmall cell lung cancer: The end of beginning? Ann. Intern. Med. 115:737-739; 1991.
15. Jeremic, B.; Shibamoto, Y.; Acimovic, L.; Djuric, L. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III nonsmall-cell lung cancer. J. Clin. Oncol. 13:452-458; 1995.
16. Johnson, D. H.; Kim, K.; Turrisi, A. T.; Sause, W.; Komaki, R.; Wagner, H.; Blum, R. Cisplatin & etoposide + concurrent thoracic radiotherapy administered once vs. twice daily for limited-stage small cell lung cancer: Preliminary results of an intergroup trial (Abstr.). Proc. Am. Soc. Clin. Oncol. 13:333; 1994.
17. Kanazawa, H.; Rapacchietta, D.; Kallman, R. F. Schedule-dependent therapeutic gain from the combination of frac-tionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems. Cancer Res. 48:3158-3164; 1987.
18. Kelly, K.; Bunn, P. A., Jr.; Hazuka, M.; Turrisi, A.; Leonard, C.; Caskey, J. A Phase I-II trial of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation followed by carboplatin in patients with regionally inoperable nonsmall cell lung cancer (Abstr.). Proc. Am. Soc. Clin. Oncol, 14:377; 1995.
19. Knox, R. J.; Friedlos, F.; Lydall, D. A.; Roberts, J. J. Mechanism of cytotoxicity of anticancer platinum drugs: Evidence that cis-diamminedichloroplatinum (II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum (II) differ only in the kinetics of their interaction with DNA. Cancer Res. 46:1972-1979; 1986.
20. Kovacs, C. J.; Schenken, L. L.; Burholt, D. R. Therapeutic potentiation of combined cis-dichlorodiammine-platinum (II) and irradiation by ICRF-159. Int. J. Radiat. Oncol. Biol. Phys. 5:1361-1364; 1979.
21. Kunitoh, H.; Tamura, T.; Saijo, N. Concurrent platinum-vindesine chemotherapy plus accelerated twice-daily radiotherapy for locally advanced nonsmall cell lung cancer: A Phase II Japan Clinical Oncology Group trial (Abstr.). Proc. Am. Soc. Clin. Oncol. 13:346; 1994.
22. Le Chevalier, T.; Arriagada, R.; Quoix, E.; Ruffie, P.; Martin, M.; Tarayre, M.; Douillard, J.-Y.; Laplanche, A. Radiotherapy alone vs. combined chemotherapy and radiotherapy in nonresectable nonsmall-cell lung cancer: First analysis of a randomized trial in 353 patients. J. Natl. Cancer Inst. 83:417-423; 1991.
23. Lelieveld, P.; Scoles, M. A.; Brown, J. M.; Kallman, R. F. The effect of treatment in fractionated schedules with the combination of x-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int. J. Radiat. Oncol. Biol. Phys. 11:111-121; 1985.
24. LeRoy, A. F.; Wehling, M. L.; Sponseller, H. L.; Friauf, W. S.; Solomon, R. E.; Dedrick, R. L. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Biochem. Med. 18:184-191; 1977.
25. Loo, J. C. K.; Riegelman, S. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after IV infusion. J. Pharm. Sci. 59:53-55; 1970.
26. McGinnis, W. L.; Shaw, E. G.; Jung, S.-H.; Jett, J.; Stella, P.; Marschke, R.; Kugler, J.; Mailliard, J.; Wiesenfeld, M.; Frytak, S.; Kuross, S.; Poon, M. Results of a phase III prospective randomized trial comparing standard thoracic radiation therapy (TRT) to twice-daily TRT +/-concomitant etoposide-cisplatin chemotherapy in patients with unresectable stage IIIA/B nonsmall cell lung cancer (Abstr.). Proc. Am. Soc. Clin. Oncol. 14:355; 1995.
27. Miller, A. B.; Hoogstraten, B.; Staquet, M.; Winkler, A. Reporting results of cancer treatment. Cancer 47:207-214; 1981.
28. Murthy, A. K.; Rossof, A. H.; Anderson, K. M.; Hendrickson, F. R. Cytotoxicity and influence on radiation dose response curve of cis-diamminedichloroplatinum II (cis-DDP). Int. J. Radiat. Oncol. Biol. Phys. 5:1411-1415; 1979.
29. Newell, D. R.; Eeles, R. A.; Gumbrell, L. A.; Boxall F. E.; Horwich, A.; Calvert, A. H. Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma. Cancer Chemother. Pharmacol. 23:367-372; 1989.
30. Nonsmall Cell Lung Cancer Collaborative Group. Chemotherapy in nonsmall cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br. Med. J. 311:899-909; 1995.
31. Ottaway, J. H. Normalization in the fitting of data by iterative methods: Application to tracer kinetics and enzyme kinetics. Biochem. J. 134:729-736; 1973.
32. Overgaard, J. Selective enhancement of radiation response in C3H mammary carcinoma with cisplatin. Cancer Treat. Rep. 65:501-503; 1981.
33. Richmond, R. C.; Zimbrick, J. D.; Hykes, D. L. Radiation-induced DNA damage and lethality in E. coli as modified by the antitumor agent cis-dichlorodiammine-platinum-(II). Radiat. Res. 71:447-460; 1977.
34. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Cox, J. D.; Emami, B.; Curran, W. J.; Byhardt, R. W.; Dar, A. R.; Turrisi, A. T. RTOG 8808 ECOG 4588, preliminary analysis of a phase III trial in regionally advanced unresectable nonsmall cell lung cancer with minimum three year follow-up (Abstr.). Int. J. Radiat. Oncol. Biol. Phys. 32(Suppl. 1):195; 1995.
35. Sause, W. T.; Scott, C.; Taylor, S.; Johnson, D.; Livingston, R.; Komaki, R.; Emami, B.; Curren, W. J.; Byhardt, R. W.; Turrisi, A. T.; Dar, A. R.; Cox, J. D. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer. J. Natl. Cancer Inst. 87:198-205; 1995.
36. Schaake-Koning, C.; van den Bogaert, W.; Dalesio, O.; Festen, J.; Hoogenhout, J.; van Houtte, P.; Kirkpatrick, A.; Koolan, M.; Maat, B.; Nijs, A.; Renaud, A.; Rodrigus, P.; Schuster-Uitterhoeve, L.; Sculier, J-P.; van Zandwijk, N.; Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable nonsmall-cell lung cancer. N. Engl. J. Med. 326:524-530; 1992.
37. Shaw, E. G.; McGinnis, W. L.; Jett, J. R.; Su, J. Q.; Frank, A. R.; Mailliard, J. A.; Engel, R. E.; Wiesenfeld, M.; Rowland. K. M., Jr. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable Stage III nonsmall-cell carcinoma of the lung. J. Natl. Cancer. Inst. 85:321-323; 1993.
38. Tanabe, M.; Godat, D.; Kallman, R. F. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/ST tumor and normal tissues of the C3H/KM mouse. Int. J. Radiat. Oncol. Biol. Phys. 13:1523-1532; 1987.
39. Thames, H. D., Jr.; Peters, L. J.; Withers, H. R.; Fletcher, G. H. Accelerated fractionation vs. hyperfractionation: Rationales for several treatments per day. Int. J. Radiat. Oncol. Biol. Phys. 9:127-138; 1983.
40. Vokes, E. E. Interactions of chemotherapy and radiation. Semin. Oncol. 20:70-79; 1993.
41. Vokes, E. E.; Weichselbaum, R. R. Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J. Clin. Oncol. 8:911-934; 1990.
42. Volling, P.; Staar, S.; Achterrath, W.; Mueller, R.-P. Carboplatin plus radiation therapy in head and neck cancer. Semin. Oncol. 18(Suppl. 2):17-22; 1991.
43. Wang, C. C. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int. J. Radiat. Oncol. Biol. Phys. 14:1143-1146; 1988.
44. Wang, C. C.; Blitzer, P. H.; Suit, H. D. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 55:2100-2104; 1985.
45. Withers, H. R. Biologic basis for altered fractionation schemes. Cancer 55:2086-2095; 1985.
46. Zubrod, C. G.; Schneiderman, M.; Frei, E.; Brindley, C.; Gold, G. L.; Schneider, B.; Oviedo, R.; Gorman, J.; Johnes, R., Jr.; Jonson, U.; Colsky, J.; Chalmers, T.; Ferguson, B.; Dederick, M.; Holland, J.; Selawry, O.; Regelson, W.; Lasagna, L.; Owens, A. H., Jr. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphamide. J. Chronic Dis. 11:7-33; 1960.